Abbott Laboratories (ABT) Change in Inventory (2009 - 2026)

Abbott Laboratories has reported Change in Inventory for 18 years, with the latest figure at $301.0 million in Q2 2026.

• Quarterly Change in Inventory rose 10133.33% year-over-year to $301.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $274.0 million (up 234.98% YoY) and the FY2025 annual result came in at -$195.0 million, down 436.21% from the prior year.
• Change in Inventory eased to $301.0 million in Q2 2026 per ABT's latest filing, from $420.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $554.0 million in Q1 2022 and troughed at -$295.0 million in Q4 2023.
• A 5-year average of $123.8 million and a median of $191.5 million in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2026: Change in Inventory plunged 256.08% in 2023, then soared 10133.33% in 2026.
• Over 5 years, Change in Inventory stood at $189.0 million in 2022, then slumped by 256.08% to -$295.0 million in 2023, then grew by 20.34% to -$235.0 million in 2024, then gained by 0.43% to -$234.0 million in 2025, then soared by 228.63% to $301.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $301.0 million, $420.0 million, and -$234.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.